23 computer-programmer-"https:"-"EMBL-EBI---European-Bioinformatics-Institute" "UCL" Fellowship positions
Sort by
Refine Your Search
-
Employee assistance programme: Staff Support Service Discounted medical insurance Please visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more. Our commitment to Equality, Diversity
-
2026 - 23:00 (Europe/Oslo) Country Norway Type of Contract Temporary Job Status Full-time Hours Per Week 37.5 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme
-
About us University College London (UCL) UCL is a multi-disciplinary university with a population of over 13,000 staff and 42,000 students from 150 different countries. Degree programmes
-
• Enhanced maternity, paternity and adoption pay • Employee assistance programme: Staff Support Service • Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out
-
therapy projects focused on neurological and neuromuscular disorders, contributing to an extensive novel therapeutic programme for RFC1 CANVAS led by Professor Andrea Cortese. The post is available from 01
-
8 Dec 2025 Job Information Organisation/Company Université Catholique de Louvain (UCL) Department ICTEAM Research Field Computer science » Computer systems Researcher Profile Recognised Researcher
-
work on the genomics of epilepsy within a wider programme of translational research, including genomics and climate change, under the supervision of Professor Sanjay Sisodiya. You will oversee a team of
-
neuroscience, cardiovascular neurophysiology, and neural computation. Researchers have access to state of the art facilities (https://www.ucl.ac.uk/science-technology-platforms/ ) and the department has close
-
(CARE) Cycle to work scheme and season ticket loan Immigration loan On-site nursery On-site gym Enhanced maternity, paternity and adoption pay Employee assistance programme: Staff Support Service
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and